Feb 26, 2024 / 10:00PM GMT
Operator
Welcome to the Fate Therapeutics Fourth Quarter 2023 financial results conference call (Operator Instructions) This call is being webcast live on the Investors section of today's Web website at Fate Therapeutics.com. As a reminder, today's call is being recorded. I would now like to introduce Scott Watsco, President and CEO of Fate Therapeutics.
Scott Wolcgko Fate Therapeutics Inc-President&CEO
Thank you. Good afternoon, and thanks, everyone, for joining us for the Fate Therapeutics Fourth Quarter 2023 financial results call shortly after 4 PM Eastern Time today, we issued a press release with these results, which can be found on the Investors section of our website under Press Releases. And in addition, our Form 10-K for the year ended December 31, 2023 was filed shortly thereafter and can be found on the Investors section of our website under Financial Information.
Before we begin, I would like to remind everyone that except for statements of historical facts, the statements made by management and responses to questions on
Q4 2023 Fate Therapeutics Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot